Equipmake has published its FY25 results, noting progress through restructuring, new technical partnerships and growing demand for its electrification systems...
Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
Likewise directors are buying shares and building new logistics capacity as the company pushes forward with growth plans despite near-term profit pressures...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...
Equipmake has published its FY25 results, noting progress through restructuring, new technical partnerships and growing demand for its electrification systems...
Aptamer Group is holding its AGM today in York, where the Chairman will outline continued commercial progress, recent contract wins with major pharmaceutical companies, and an FY26 order book of £1.95 million...
Likewise directors are buying shares and building new logistics capacity as the company pushes forward with growth plans despite near-term profit pressures...
AstraZeneca has received US approval for Imfinzi combined with FLOT chemotherapy for adults with resectable early-stage and locally advanced gastric and gastroesophageal junction cancers...